(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KERASKIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

KERASKIN

ST13

US500000077215519

Class

5, 9, 10

Filing

77215519

Registration

3686617

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

05/25/2023

Classification

Registered

Trademark type

Combined

Nice classes

5, 9, 10

Filing date

06/26/2007

Registration date

09/22/2009

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/18/2019

Last transaction

10/18/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/01/2002

First use in commerce

04/05/2005

Drawing code

5

Owner type

03

Owner location

Gangnam-gu, Seoul, KR

Examiner

LUDEMAN, JESSICA ANN

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Modern Cell & Tissue Technologies Inc.

Representatives

Michelle P. Ciotola Cantor Colburn LLP

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biological preparations for pharmaceutical purposesPharmaceutical preparations for use in cell therapy of wounded skinBiological skin tissue intended for subsequent implantationPharmaceutical preparations for skin regenerationPharmaceutical preparations for the treatment of burnsPharmaceutical preparations for the treatment of skin ulcers

Class 9

Artificial skin for testing safety and efficacy of pharmaceuticsArtificial skin for testing safety and efficacy of cosmeticsArtificial skin for research of skin carcinogenesisArtificial skin for testing inflammatory agentsArtificial skin for testing potential irritantsArtificial skin for testing potential allergensArtificial skin for testing skin whitening agentsArtificial skin for testing transdermal absorption of pharmaceutics

Class 10

Artificial skin for surgical purposesArtificial skin for the replacement of skin

Publications

History of USPTO decisions and trademark events.

53 publications found

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/25/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/25/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/25/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/25/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/25/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/25/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/04/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/04/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/04/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/04/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/18/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/18/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/18/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/18/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

09/11/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/22/2018

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/07/2016

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/07/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/07/2016

ES8R

TEAS SECTION 8 RECEIVED

02/11/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

09/22/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

08/19/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/18/2009

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/28/2009

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/28/2009

IUAF

USE AMENDMENT FILED

07/06/2009

EISU

TEAS STATEMENT OF USE RECEIVED

07/06/2009

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/11/2009

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/11/2009

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

01/06/2009

PUBO

PUBLISHED FOR OPPOSITION

10/14/2008

NPUB

NOTICE OF PUBLICATION

09/24/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/11/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/10/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/28/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/28/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/25/2008

PETG

PETITION TO REVIVE-GRANTED

07/25/2008

PROA

TEAS PETITION TO REVIVE RECEIVED

07/25/2008

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

07/21/2008

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

07/19/2008

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

12/10/2007

GPRA

PRIORITY ACTION E-MAILED

12/10/2007

CPRA

PRIORITY ACTION WRITTEN

12/10/2007

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

12/10/2007

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/09/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/30/2007

ALIE

ASSIGNED TO LIE

10/30/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/27/2007

DOCK

ASSIGNED TO EXAMINER

09/26/2007

NWAP

NEW APPLICATION ENTERED

06/29/2007

Continuous trademark protection

Get notified about every new filing that threatens KERASKIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.